Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giorgia Bertazzoni is active.

Publication


Featured researches published by Giorgia Bertazzoni.


Toxicology in Vitro | 2002

Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes

Cristina Magnoni; E. Euclidi; Luisa Benassi; Giorgia Bertazzoni; Andrea Cossarizza; Stefania Seidenari; Alberto Giannetti

The sphingomyelin pathway is an ubiquitous, evolutionary conserved signaling system which transduces an extracellular signal into the cell. During the past few years increasing evidence has shown that the sphingolipid ceramide may play a role as a second messenger in intracellular signal transduction. The ceramide generation via sphingomyelinase (SMase) is followed by three major cellular responses: cell growth arrest, induction of cell differentiation and/or induction of programmed cell death or apoptosis. The aim of this study is to investigate whether activation of SMases and generation of ceramide can be induced by UVB radiation in normal human keratinocytes. The present data show that exposure to UVB radiation results in rapid generation of ceramide. The ceramide accumulation starts 15 min after UV exposure and progressively increases up to 24 h. In vitro measurement of SMase activity following exposure to UVB evidences an activation of both neutral and acidic SMases. Moreover, UVB induces apoptosis in normal human keratinocytes as shown by TUNEL technique and FACS analysis. These data indicate that UVB induced ceramide generation and activation of both neutral and acidic SMases, suggesting that sphingolipids metabolism may be involved in the UVB signaling pathway.


Journal of Cutaneous Pathology | 2012

Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes

Giovanni Ponti; Sabina Nasti; Lorena Losi; Lorenza Pastorino; Annamaria Pollio; Luisa Benassi; Stefania Giudice; Giorgia Bertazzoni; Eugenia Veratti; Paola Azzoni; Giovanna Bianchi Scarrà; Stefania Seidenari

Brooke‐Spiegler syndrome represents an autosomal dominant disease characterized by the occurrence of multiple cylindromas, trichoepitheliomas and (sporadically) spiroadenomas. Patients with Brooke‐Spiegler syndrome are also at risk of developing tumors of the major and minor salivary glands. Patients with Brooke‐Spiegler syndrome have various mutations in the CYLD gene, a tumor‐suppressor gene located on chromosome 16q. To date, 68 unique CYLD mutations have been identified. We describe two families with Brooke‐Spiegler syndrome, one with familial cylindromatosis and one with multiple familial trichoepithelioma, which showed wide inter‐family phenotypic variability. Analysis of germline mutations of the CYLD and PTCH genes was performed using peripheral blood. In addition, formalin‐fixed paraffin‐embedded tumor samples were analyzed for PTCH somatic mutations and cylindroma cell cultures were obtained directly from patients for further growth and analysis. Clinically, the major features of Brooke‐Spiegler syndrome include the presence of heterogeneous skin tumors and wide inter‐ and intra‐familial phenotypic variability. Histopathologically, both cylindromas and trichoepitheliomas were found in affected individuals. Mutations or loss of heterozygosity was not found in CYLD and PTCH genes. In CYLD and PTCH mutation‐negative patients, other genes may be affected and further studies are needed to clarify whether these patients may be affected by de novo germline mutations.


Contact Dermatitis | 1999

In vitro testing of tensides employing monolayer cultures: a comparison with results of patch tests on human volunteers

Luisa Benassi; Giorgia Bertazzoni; Stefania Seidenari

Evaluation of the irritant potential of new products or ingredients prior to human testing is generally performed in vivo on animals. However, according to the 6th amendment and following updates of the European Community directive on cosmetic products (93/35/EEC), animal testing will be banned when suitable substitutes will be available. To know whether in vitro tests for assessment of skin irritancy provide results approaching human conditions, comparisons have to be made between data deriving from in vitro tests and skin response in humans. The aim of our study was to assess the validity of the monolayer culture system of normal human keratinocytes as a model for the evaluation of the irritant effects of detergents, by comparing in vitro cell culture data to in vivo acute skin irritancy effects of cocamidopropyl betaine (CAPB), an amphoteric compound, Tween 20 (TW20) (polysorbate 20) and Tween 80 (TW80) (polysorbate 80), representing nonionic compounds, applied to the skin of 24 healthy volunteers at a concentration similar to that employed in commercial products. As parameters for cytotoxicity, cell proliferation, cell membrane integrity and cell metabolism were assessed by cell counts, thymidine incorporation, MTT conversion, and Neutral Red uptake. In order to increase the sensitivity of the in vivo evaluation, bioengineering methods for assessment of the effects of test products on the skin were employed. Whereas all 4 in vitro methods ranked the tensides according to their toxicity in the following order: CAPB>SLS>TW20>TW80, both in vivo methods agreed in identifying SLS as the most irritating substance. Moreover, as compared with the irritation potential on human skin, all 4 in vitro tests overestimated the toxicity of CAPB. This suggests that the keratinocyte monolayer cell culture technique cannot directly replace in vivo methods, and that data obtained by this method should be interpreted cautiously.


Applied Immunohistochemistry & Molecular Morphology | 2014

Stem cell properties in cell cultures from different stage of melanoma progression.

Cristina Magnoni; Stefania Giudice; Giovanni Pellacani; Giorgia Bertazzoni; Caterina Longo; Eugenia Veratti; Daria Morini; Luisa Benassi; Cristina Vaschieri; Paola Azzoni; Anto De Pol; Stefania Seidenari; Aldo Tomasi; Annamaria Pollio; Giovanniv Ponti

Cutaneous melanoma is an extremely heterogenous human cancer. The most aggressive melanoma may contain deregulated cells with undifferentiated/stem cell-like phenotype. A critical mechanism by which melanoma cells enhance their invasive capacity is the dissolution of the intercellular adhesion and the acquisition of mesenchymal features as a part of an epithelial-to-mesenchymal transition. The aim of this study was to clarify the role of a stem cell-like population in human melanomas by means of melanocytic cell culture analysis obtained from distinct histotypes of primary and metastatic malignant melanoma. Patients with advanced melanoma >2 cm in diameter and/or >300 mm2 surface were enrolled. The melanoma cells were isolated from skin biopsies of lentigo maligna melanoma, superficial spreading melanoma, nodular melanoma, and metastatic melanoma. The colony forming unit assay and alkaline phosphatase stain were evaluated. Cells were subsequently cultured and maintained in different media to evaluate their ability to differentiate into osteogenic and adipogenic lineages. Immunohistochemistry and flow cytometry analysis were performed to evaluate antigenic markers CD90, CD73, CD105, CD146, CD20, CD166, and Nestin. This study confirms that melanoma can include heterogenous cell populations with the ability both to self-renew and to a give rise to differentiated progeny. Melanoma cells displayed intratumoral heterogeneity and dynamic antigen phenotypes. Histologically, transitions from normal skin to melanoma were associated with a gradual increase in the expression of CD146, CD20, CD133, Nestin, and CD73. These molecular profiles could be further analyzed and, in the future, used for the development of novel biomolecular targeted-therapy approaches.


Skin Pharmacology and Applied Skin Physiology | 2003

Decrease in toxic potential of mixed tensides maintained below the critical micelle concentration: an in vitro study.

Luisa Benassi; Giorgia Bertazzoni; Cristina Magnoni; Marcella Rinaldi; Claudio Fontanesi; Stefania Seidenari

Sodium lauryl sulphate (SLS) is an anionic tenside widely utilized in commercial topical preparations that may cause skin irritation. It has been shown that the barrier damage caused by SLS in vivo is lower when SLS is used in combination with other tensides which are able to reduce the critical micelle concentration (CMC). The aim of our study was to evaluate if the cytotoxic effect of SLS is reduced by the association with different tensides also at concentrations well below the CMC. Normal human keratinocytes from plastic surgery were grown in serum-free medium. At subconfluency, the cells were treated with SLS at a dose of 0.0025% in combination with cocamidopropyl betaine, Tween 20 and Tween 80 at the minimum toxic dose. Following tenside treatment, the culture medium was changed, and after 24 h the cells were collected for 3H-thymidine incorporation, the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay and neutral red (NR) uptake. The cytotoxic effect on normal human keratinocytes, as evaluated by 3H-thymidine incorporation, MTT assay and NR uptake, was significantly decreased by the combination with all the tested tensides. The correlation between cytotoxicity and physical properties was also studied by a conductimetric assay to investigate the mechanism involved in this toxicity reduction.


Investigational New Drugs | 2012

Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines

Stefania Giudice; Luisa Benassi; Giorgia Bertazzoni; Eugenia Veratti; Daria Morini; Paola Azzoni; Maria Paola Costi; Alberto Venturelli; Silvia Pirondi; Stefania Seidenari; Cristina Magnoni

SummaryMelanoma is one of the most common cancers, and its incidence has continued to increase over the past few decades. Chemotherapy resistance and related defects in apoptotic signaling are critical for the high mortality of melanoma. Effective drugs are lacking because apoptosis regulation in this tumor type is not well understood. The folate pathway has been considered an interesting target for anticancer therapies, and approaches targeting this pathway have recently been extended to melanoma treatment. In this study, the intracellular apoptosis signaling pathways of two melanoma cells lines (SK-MEL-2 and SK-MEL-28) were investigated after treatment with a new experimental antifolate substance (MR36) that targets thymidylate synthase. In both melanoma cell lines, apoptosis induction was triggered by a p53-independent mechanism. MR36-induced apoptosis was associated with a loss of both mitochondrial membrane potential and caspase-3 activation. Induction of cell cycle arrest by MR36 was associated with changes in the expression of key cell cycle regulators, such as p21 and cyclin D1, and the hypophosphorylation of pRb. In addition, Fas signaling was also analyzed. These findings suggest that, unlike classical antifolates, MR36 exerted an inhibitory effect on both the enzymatic function and expression of thymidylate synthase, thereby inducing apoptosis through the activation of the extrinsic and intrinsic pathways in the melanoma cell lines. MR36 showed a different mechanism of action from the known antifolates (Nolatrexed and Pemetrexed) that resulted in higher anticancer activity. Therefore, MR36 should be included as a potential new therapeutic treatment in melanoma research.


BioMed Research International | 2013

Proteomic analysis of PTCH1+/- fibroblast lysate and conditioned culture media isolated from the skin of healthy subjects and nevoid basal cell carcinoma syndrome patients.

Giovanni Ponti; Giorgia Bertazzoni; Lorenza Pastorino; Emanuela Monari; Aurora Cuoghi; Stefania Bergamini; Elisa Bellei; Luisa Benassi; Paola Azzoni; Tiziana Petrachi; Cristina Magnoni; Giovanni Pellacani; Pietro Loschi; Annamaria Pollio; Alexander Witkowski; Aldo Tomasi

Background. The pathogenesis underlying the increased predisposition to the development of basal cell carcinomas (BCCs) in the context of Gorlin-Goltz syndrome is linked to molecular mechanisms that differ from sporadic BCCs. Patients with Gorlin syndrome tend to develop multiple BCCs at an early age and present with tumors of non-sun-exposed skin. The aim of this study was to compare the proteomic profile of cultured fibroblast and fibroblast conditioned culture media of PTCH1+ and nonmutated fibroblasts. Results. Proteomic analysis was performed using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight mass spectrometry in PTCH1+ fibroblast conditioned media isolated from not affected sun-protected skin areas of Gorlin patients and from healthy subjects. 12 protein cluster peaks, >5 kDa, had significant differences in their peak intensities between PTCH1+ and PTCH1− subject groups. We detected a strongly MMP1 overexpression in PTCH1+ fibroblasts obtained from NBCCS patients with respect to healthy donors. Conclusion. Protein profiles in the fibroblast conditioned media revealed statistically significant differences between two different types (missense versus nonsense) of PTCH1 mutations. These differences could be useful as signatures to identify PTCH1 gene carriers at high risk for the development of NBCCS-associated malignancies and to develop novel experimental molecular tailored therapies based on these druggable targets.


Anticancer Research | 2011

18β-Glycyrrhetinic Acid and Glabridin Prevent Oxidative DNA Fragmentation in UVB-irradiated Human Keratinocyte Cultures

Eugenia Veratti; Tiziana Rossi; Stefania Giudice; Luisa Benassi; Giorgia Bertazzoni; Daria Morini; Paola Azzoni; Elisa Bruni; Alberto Giannetti; Cristina Magnoni


Toxicology in Vitro | 2007

New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines.

Stefania Giudice; Luisa Benassi; Giorgia Bertazzoni; Maria Paola Costi; Arianna Gelain; Alberto Venturelli; Chiara Bernardi; Giulio Gualdi; Andrea Coppi; Tiziana Rossi; Alberto Giannetti; Cristina Magnoni


Anticancer Research | 2006

Pharmacological and Toxicological Evaluation of a New Series of Thymidylate Synthase Inhibitors as Anticancer Agents

Luisa Benassi; Cristina Magnoni; Stefania Giudice; Giorgia Bertazzoni; Maria Paola Costi; Marcella Rinaldi; Alberto Venturelli; Andrea Coppi; Tiziana Rossi

Collaboration


Dive into the Giorgia Bertazzoni's collaboration.

Top Co-Authors

Avatar

Luisa Benassi

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Cristina Magnoni

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Stefania Seidenari

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Alberto Giannetti

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Stefania Giudice

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

A. Di Nardo

University of California

View shared research outputs
Top Co-Authors

Avatar

Paola Azzoni

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

E. Euclidi

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Eugenia Veratti

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Alberto Venturelli

University of Modena and Reggio Emilia

View shared research outputs
Researchain Logo
Decentralizing Knowledge